These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11231910)

  • 1. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty.
    Cipollone F; Marini M; Fazia M; Pini B; Iezzi A; Reale M; Paloscia L; Materazzo G; D'Annunzio E; Conti P; Chiarelli F; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):327-34. PubMed ID: 11231910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
    Cipollone F; Ferri C; Desideri G; Paloscia L; Materazzo G; Mascellanti M; Fazia M; Iezzi A; Cuccurullo C; Pini B; Bucci M; Santucci A; Cuccurullo F; Mezzetti A
    Circulation; 2003 Dec; 108(22):2776-82. PubMed ID: 14623801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma antigen levels of monocyte chemoattractant protein-1 in patients with restenosis after percutaneous transluminal coronary angioplasty.
    Hokimoto S; Ogawa H; Saito T; Oshima S; Noda K; Soejima H; Takazoe K; Date H; Ishibashi F; Nakamura S; Yasue H
    Jpn Circ J; 2000 Nov; 64(11):831-4. PubMed ID: 11110426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin incompletely prevent MCP-1-dependent restenosis after percutaneous coronary intervention [corrected] in patients with coronary artery disease.
    Inami N; Nomura S; Shimazu T; Manabe K; Kimura Y; Iwasaka T
    J Thromb Thrombolysis; 2007 Dec; 24(3):267-73. PubMed ID: 17486299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine expression in coronary circulation after coronary angioplasty as a prognostic factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Fujikawa H; Shimada K
    Atherosclerosis; 2001 May; 156(1):165-70. PubMed ID: 11369010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines on the rise : mcp-1 and restenosis.
    Schmidt AM; Stern DM
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):297-9. PubMed ID: 11231906
    [No Abstract]   [Full Text] [Related]  

  • 7. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Heart; 2000 Jul; 84(1):83-7. PubMed ID: 10862597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High preprocedural non-HDL cholesterol is associated with enhanced oxidative stress and monocyte activation after coronary angioplasty: possible implications in restenosis.
    Cipollone F; Fazia M; Iezzi A; Pini B; Costantini F; De Cesare D; Paloscia L; Materazzo G; D'Annunzio E; Bucciarelli T; Vecchiet J; Chiarelli F; Cuccurullo F; Mezzetti A
    Heart; 2003 Jul; 89(7):773-9. PubMed ID: 12807855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cytokines in the pathogenesis of restenosis after percutaneous transluminal coronary angioplasty.
    Tashiro H; Shimokawa H; Sadamatsu K; Aoki T; Yamamoto K
    Coron Artery Dis; 2001 Mar; 12(2):107-13. PubMed ID: 11281299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte Chemoattractant Protein-1 Levels and Postangioplasty Restenosis of Arteriovenous Fistulas.
    Wu CC; Chen TY; Hsieh MY; Lin L; Yang CW; Chuang SY; Tarng DC
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):113-121. PubMed ID: 27797894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of monocyte chemoattractant protein-1 in atherectomy specimens from patients with restenosis after percutaneous transluminal coronary angioplasty.
    Hokimoto S; Oike Y; Saito T; Kitaoka M; Oshima S; Noda K; Moriyama Y; Ishibashi F; Ogawa H
    Circ J; 2002 Jan; 66(1):114-6. PubMed ID: 11999660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment.
    Pietersma A; Kofflard M; de Wit LE; Stijnen T; Koster JF; Serruys PW; Sluiter W
    Circulation; 1995 Mar; 91(5):1320-5. PubMed ID: 7867168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty.
    Economou E; Tousoulis D; Katinioti A; Stefanadis C; Trikas A; Pitsavos C; Tentolouris C; Toutouza MG; Toutouzas P
    Int J Cardiol; 2001 Aug; 80(1):55-60. PubMed ID: 11532547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
    Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
    Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
    Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
    Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma monocyte chemoattractant protein-1 antigen levels and the risk of restenosis after coronary stent implantation.
    Oshima S; Ogawa H; Hokimoto S; Nakamura S; Noda K; Saito T; Soejima H; Takazoe K; Ishibashi F; Yasue H
    Jpn Circ J; 2001 Apr; 65(4):261-4. PubMed ID: 11316119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
    Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
    Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.